Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
mesothelioma
Biotech
Atara reviewing patient death in mesothelioma CAR-T study
Atara Biotherapeutics said a patient in an early-stage study of its CAR-T cell therapy has died.
Kyle LaHucik
Feb 18, 2022 1:05pm
Biopharma charts progress in translating CAR-T to solid cancers
Dec 15, 2021 3:00am
Sanofi inks $270M cancer AI deal with developer Owkin
Nov 18, 2021 1:30am
SITC: Cellectis off-the-shelf CAR-T active in solid tumor models
Nov 12, 2021 10:50am
Cedilla adds $25M to series B to test two cancer drugs in trials
Oct 25, 2021 6:30am
Novocure’s electric field therapy nets CE mark in mesothelioma
Nov 11, 2020 10:35am